Exopharm
(ASX:EX1)

Exopharm (ASX: EX1) has changed its name to Tryptamine Therapeutics - TYP (ASX: TYP).
Below are the previous articles from Exopharm (ASX: EX1):

Health & Biotech

Health: Poor pigs and dairy performance offsets feedlot wins at Apiam

August 26, 2019August 8, 2024 | Daniel Paproth

Health & Biotech

There’s a bit of promise for health small caps in the federal Budget – but there’s also a big ‘if’

April 2, 2019August 8, 2024 | Daniel Paproth

Health & Biotech

Health: Neurotech fires a strategic adviser after claims he’s a dud, shares fall 17pc

March 27, 2019August 8, 2024 | Daniel Paproth

IPO Watch

IPO Watch: Uniti Wireless set to ring the ASX bell today; four contenders take their mark

February 13, 2019August 8, 2024 | Angela East

News

Capital crunch hits ASX as fundraisings plunge 34pc

January 4, 2019August 8, 2024 | Rachel Williamson

IPO Watch

IPOs of 2018: The few that floated when most didn’t

December 21, 2018October 1, 2024 | Rachel Williamson

IPO Watch

IPO Watch: Exopharm wants to raise $7m to help you live longer

November 12, 2018August 8, 2024 | Rachel Williamson